- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 10.58M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 9.91M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 5.3M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $1.15K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.07M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.88M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $103.85K |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $205.4K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.24M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $3.48M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$7.87M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$5.81M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$12.84M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$19.39M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $13.86M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $14.28M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $17.3M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $17.59M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.71M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $4.08M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $9.44M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $11.78M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.53 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.72 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.53 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.72 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $3.98M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $5.75M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$5.23M |
| Net Income | Q1 2026 · Dec 31, 2025 | −$3.81M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.81M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.98M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$5.75M |